Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medical treatment for gastro-entero-pancreatic neuroendocrine tumours
Rossana Berardi, Francesca Morgese, Mariangela Torniai, et al.
World Journal of Gastrointestinal Oncology (2016) Vol. 8, Iss. 4, pp. 389-389
Open Access | Times Cited: 19

Showing 19 citing articles:

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
Anna Kathrin Stueven, Antonin Kayser, Christoph Wetz, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 3049-3049
Open Access | Times Cited: 171
Sunitinib in the Treatment of Thyroid Cancer
Silvia Martina Ferrari, Marco Centanni, Camilla Virili, et al.
Current Medicinal Chemistry (2017) Vol. 26, Iss. 6, pp. 963-972
Open Access | Times Cited: 77
PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity
Martina Ferrata, Arno Schad, S. Zimmer, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 60
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study
Sara Massironi, Federica Facciotti, Federica Cavalcoli, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 692-692
Open Access | Times Cited: 16
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
Giovanni Vitale, Alessandra Dicitore, Luigi Barrea, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 3, pp. 511-525
Open Access | Times Cited: 23
Chemotherapy in NETs: When and how
Anna Angelousi, Gregory Kaltsas, Anna Koumarianou, et al.
Reviews in Endocrine and Metabolic Disorders (2017) Vol. 18, Iss. 4, pp. 485-497
Closed Access | Times Cited: 24
Analysis of recurrence after the resection of pancreatic neuroendocrine tumors
Konstantinos Chouliaras, Naeem A. Newman, Mrinal Shukla, et al.
Journal of Surgical Oncology (2018) Vol. 118, Iss. 3, pp. 416-421
Closed Access | Times Cited: 21
Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs
Hiroki R. Ueda, Yoshimitsu Akiyama, Shu Shimada, et al.
Endocrine Related Cancer (2018) Vol. 25, Iss. 6, pp. 619-631
Open Access | Times Cited: 20
68-Gallium DOTATATE Scanning in Symptomatic Patients with Negative Anatomic Imaging But Suspected Neuroendocrine Tumor
Jasmine Shell, Xavier M. Keutgen, Corina Millo, et al.
International Journal of Endocrine Oncology (2018) Vol. 5, Iss. 1
Open Access | Times Cited: 19
Somatostatin receptor expression in parathyroid neoplasms
Sara Storvall, Helena Leijon, Eeva Ryhänen, et al.
Endocrine Connections (2019) Vol. 8, Iss. 8, pp. 1213-1223
Open Access | Times Cited: 17
Progress in Endocrine Neoplasia
Samuel A. Wells
Clinical Cancer Research (2016) Vol. 22, Iss. 20, pp. 4981-4988
Open Access | Times Cited: 13
Apatinib inhibits tumor growth and angiogenesis in PNET models
Shan Wu, Jianjun Zhou, Jing Guo, et al.
Endocrine Connections (2018) Vol. 8, Iss. 1, pp. 8-19
Open Access | Times Cited: 7
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study
Manuela Albertelli, Elena Nazzari, Stefania Sciallero, et al.
Journal of Endocrinological Investigation (2017) Vol. 40, Iss. 11, pp. 1265-1269
Closed Access | Times Cited: 4
Signaling networks and the feasibility of computational analysis in gastroenteropancreatic neuroendocrine tumors
Pengchen Chen, Qingshui Wang, Jian‐Wei Xie, et al.
Seminars in Cancer Biology (2019) Vol. 58, pp. 80-89
Closed Access | Times Cited: 2
Gastro-entero-pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: a therapy update
Flavio Tonelli, Francesca Marini, Francesca Giusti, et al.
International Journal of Endocrine Oncology (2017) Vol. 4, Iss. 1, pp. 43-58
Closed Access | Times Cited: 1
Possibilities of treating patients with generalized neuroendocrine tumors
Н. А. Майстренко, P. N. Romashchenko, Р. В. Орлова, et al.
P A Herzen Journal of Oncology (2018) Vol. 7, Iss. 2, pp. 16-16
Open Access | Times Cited: 1
Malignant behavior of a well‑differentiated digestive neuroendocrine tumor with peritoneal carcinomatosis: A case report
Klara Wyffels, C. D. Wilde, Jacques Van Huysse, et al.
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 6
Open Access
Recent advances in the management of endocrine malignancies associated with hereditary hyperparathyroidism syndromes
Yu‐Long Li, William F. Simonds
International Journal of Endocrine Oncology (2017) Vol. 4, Iss. 2, pp. 85-102
Open Access
Who were those MEN hiding behind the Ulcers?: A Case Report
Shazatul Reza Binti Mohd Redzuan, Yong Sy Liang
Journal of the ASEAN Federation of Endocrine Societies (2020) Vol. 35, Iss. 2, pp. 210-214
Open Access
Page 1

Scroll to top